Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second malignancy complicating Hodgkin's disease.

E Tawil, J P Mercier

    Journal of the Canadian Association of Radiologists
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rapid evolution of the DNA-binding site in LAGLIDADG homing endonucleases.

    Nucleic acids research·2001
    Same author

    Mass spectrometric study of randomly methylated beta-cyclodextrins using ionspray, atmospheric pressure chemical ionization and matrix-assisted laser desorption/ionization.

    Rapid communications in mass spectrometry : RCM·2000
    Same author

    Liquid chromatography analysis of phosphonic acids on porous graphitic carbon stationary phase with evaporative light-scattering and mass spectrometry detection.

    Journal of chromatography. A·1999
    Same author

    Identification of phosphonic acids by capillary electrophoresis-ionspray mass spectrometry.

    Journal of chromatography. A·1998
    Same author

    [Ceramic implants to benefit complete lower dentures].

    Revue de stomatologie et de chirurgie maxillo-faciale·1998
    Same author

    Capillary electrophoresis analysis of chemical warfare agent breakdown products. I. Counterelectroosmotic separation of alkylphosphonic acids and their monoester derivatives.

    Journal of chromatography. A·1996
    Same journal

    Balloon therapy for obesity--when the balloon bursts.

    Journal of the Canadian Association of Radiologists·1985
    Same journal

    An unusual radiological artefact: a nipple ring.

    Journal of the Canadian Association of Radiologists·1985
    Same journal

    Another look at the "ring-around-the-artery" in pneumomediastinum.

    Journal of the Canadian Association of Radiologists·1985
    Same journal

    Computed tomography used to exclude pneumothorax in bullous lung disease.

    Journal of the Canadian Association of Radiologists·1985
    Same journal

    Intrapetrous intracavernous fusiform aneurysm of the internal carotid artery.

    Journal of the Canadian Association of Radiologists·1985
    Same journal

    CT of myeloma involving the skull base.

    Journal of the Canadian Association of Radiologists·1985
    See all related articles

    Patients treated for Hodgkin

    Area of Science:

    • Oncology
    • Cancer Epidemiology
    • Clinical Research

    Background:

    • Hodgkin's disease is a cancer of the lymphatic system.
    • Understanding the long-term risks associated with its treatment is crucial for patient care.

    Purpose of the Study:

    • To assess the incidence of second malignancies in patients treated for Hodgkin's disease.
    • To evaluate the relationship between specific treatment modalities and the risk of secondary cancers.

    Main Methods:

    • Retrospective review of medical records for 227 Hodgkin's disease patients diagnosed between 1969 and 1977.
    • Analysis of observed versus expected malignancy ratios across different treatment subgroups (radiotherapy alone, radiotherapy plus chemotherapy, radiotherapy plus maintenance chemotherapy).
    • Detailed case analysis of patients who developed a second malignancy.

    Related Experiment Videos

    Main Results:

    • Fourteen patients (6.17%) developed second malignancies, including 10 solid tumors and 4 acute leukemias.
    • The risk of second malignancy increased significantly with treatment intensity: observed/expected ratios were 1.58 (radiotherapy alone), 5.17 (radiotherapy + chemotherapy), and 14.73 (radiotherapy + maintenance chemotherapy).
    • Treatment-induced malignancies were aggressive, with 12 of 14 patients dying within one year of diagnosis.

    Conclusions:

    • Combined radiotherapy and chemotherapy, particularly with maintenance therapy, significantly increases the risk of second malignancies in Hodgkin's disease survivors.
    • These treatment-induced secondary cancers are often aggressive and associated with poor prognosis.
    • Further research into less toxic treatment strategies is warranted to mitigate long-term risks.